Literature DB >> 22289155

Vitrification of human embryos previously cryostored by either slow freezing or vitrification results in high pregnancy rates.

James Stanger1, Jesmine Wong, Jason Conceicao, John Yovich.   

Abstract

Occasionally, clinical scenarios arise where embryos, previously cryostored and warmed, need to be recryopreserved. The outcome of 30 such transfer cycles from 25 women where embryos were recryopreserved is detailed. In 16 cases, embryos were initially cryopreserved by slow freezing and in 14 cases by vitrification. The cryopreservation stages were the pronuclear stage (n = 16), day-3 cleavage stage (n = 12), blastocyst (n = 1) and oocytes (n = 1). All recryopreservation was by Cryotop-based vitrification. From this mixed source, 30/31 twice-cryopreserved embryos survived warming and were transferred, resulting in 13 pregnancies, 11 deliveries with normal gestational age and birthweight, one pre-term birth at 33 weeks and two miscarriages. There were no malformations reported for the live births. Recryopreservation using vitrification by CryoTop has been used in a variety of clinical scenarios to preserve surplus cryopreserved embryos. The current study, although limited in numbers, resulted in high survival rates, clinical pregnancy rates similar to once-cryopreserved embryos and healthy live births independently of the initial stage and cryopreservation method. The technique may increasingly be applicable to elective single-embryo transfer and blastocyst transfer to maximize the pregnancy rate while minimizing the number of cryopreserved embryo transfers. Copyright Â
© 2011 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22289155     DOI: 10.1016/j.rbmo.2011.11.013

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  6 in total

1.  Vitrification of human blastocysts previously cryopreserved by slow controlled-rate freezing at the cleavage stage.

Authors:  S Lierman; E Van den Abbeel; P De Sutter
Journal:  J Assist Reprod Genet       Date:  2014-01-04       Impact factor: 3.412

2.  Day 5 versus Day 6 blastocyst transfers: a systematic review and meta-analysis of clinical outcomes.

Authors:  Mathilde Bourdon; Khaled Pocate-Cheriet; Astri Finet de Bantel; Veronika Grzegorczyk-Martin; Aureli Amar Hoffet; Elisangela Arbo; Marine Poulain; Pietro Santulli
Journal:  Hum Reprod       Date:  2019-10-02       Impact factor: 6.918

3.  Accumulation of Cleavage-Stage Embryos by Vitrification may Compromise Embryonic Developmental Potential in Preimplantation Genetic Testing.

Authors:  Shun Xiong; Xiangwei Hao; Yang Gao; Lihong Wu; Junxia Liu; Jiang Wang; Jiahong Zhu; Jingyu Li; Dongyun Liu; Wei Han; Guoning Huang
Journal:  Reprod Sci       Date:  2022-02-25       Impact factor: 3.060

4.  Assessment of clinical application of preimplantation genetic screening on cryopreserved human blastocysts.

Authors:  Min Liu; Yu Su; Wei-Hua Wang
Journal:  Reprod Biol Endocrinol       Date:  2016-04-08       Impact factor: 5.211

5.  Chromosome abnormalities and viability of vitrified eight-cell mouse embryos at presence of two different cryoprotectants at different storage durations.

Authors:  Shabnam Zarei Moradi; Anahita Mohseni Meybodi; Hamid Gourabi; Hossein Mozdarani; Zahra Mansouri
Journal:  Cell J       Date:  2013-02-20       Impact factor: 2.479

6.  Comparison of differences in development potentials between frozen-thawed D5 and D6 blastocysts and their relationship with pregnancy outcomes.

Authors:  Hongyi Yang; Qingling Yang; Shanjun Dai; Gang Li; Haixia Jin; Guidong Yao; Yingpu Sun
Journal:  J Assist Reprod Genet       Date:  2016-04-21       Impact factor: 3.357

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.